Skip to main content
Log in

ASCO value framework shows relative value of antineoplastics

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. American Society of Clinical Oncology

  2. 2015 US dollars

Reference

  • Foote J, et al. ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian Cancer. Journal of Oncology Practice : JOP2017025106, 10 Oct 2017. Available from: URL: http://doi.org/10.1200/JOP.2017.025106

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ASCO value framework shows relative value of antineoplastics. PharmacoEcon Outcomes News 790, 5 (2017). https://doi.org/10.1007/s40274-017-4450-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4450-5

Navigation